Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?

Zacks11-13

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483836508?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OL7xfT5pzuzwP2wxb1pcSw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2","is_english":true,"pubTime":"2024-11-13 22:15","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483836508","market":"us","top_or_hot":-1,"title":"Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?","media":"Zacks","content":"<div>\n<p>Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session....</p>\n\n<a href=\"https://finance.yahoo.com/news/cencora-inc-cor-hits-fresh-141505392.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-13 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cencora-inc-cor-hits-fresh-141505392.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session....</p>\n\n<a href=\"https://finance.yahoo.com/news/cencora-inc-cor-hits-fresh-141505392.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4529","symbol_name":"IDC概念","start_time":0,"source_url":"https://finance.yahoo.com/news/cencora-inc-cor-hits-fresh-141505392.html","article_id":"2483836508","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OL7xfT5pzuzwP2wxb1pcSw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483836508","pubTimestamp":1731507305,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Have you been paying attention to shares of Cencora ?Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session. Cencora has gained 21.1% since the start of the year compared to the 3.1% move for the Zacks Medical sector and the -5.2% return for the Zacks Medical Services industry.The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on November 6, 2024, Cencora reported EPS of $3.34 versus consensus estimate of $3.21 while it beat the consensus revenue estimate by 1.76%.For the current fiscal year, Cencora is expected to post earnings of $14.88 per share on $315.26 billion in revenues. This represents an 8.14% change in EPS on a 7.25% change in revenues. For the next fiscal year, the company is expected to earn $16.29 per share on $336.52 billion in revenues. This represents a ye","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4529":"IDC概念","BK4175":"保健护理产品经销商","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","COR":"CENCORA","BK4588":"碎股","BK4154":"管理型保健护理","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","BK4084":"特种房地产投资信托","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","HQY":"HealthEquity"},"translate_title":"Cencora，Inc.（COR）创下新高：还有运行空间吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COR":1,"HQY":0.9},"content_text":"Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session. Cencora has gained 21.1% since the start of the year compared to the 3.1% move for the Zacks Medical sector and the -5.2% return for the Zacks Medical Services industry.\nWhat's Driving the Outperformance?\nThe stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on November 6, 2024, Cencora reported EPS of $3.34 versus consensus estimate of $3.21 while it beat the consensus revenue estimate by 1.76%.\nFor the current fiscal year, Cencora is expected to post earnings of $14.88 per share on $315.26 billion in revenues. This represents an 8.14% change in EPS on a 7.25% change in revenues. For the next fiscal year, the company is expected to earn $16.29 per share on $336.52 billion in revenues. This represents a year-over-year change of 9.46% and 6.74%, respectively.\nValuation Metrics\nCencora may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.\nOn this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.\nCencora has a Value Score of A. The stock's Growth and Momentum Scores are A and D, respectively, giving the company a VGM Score of A.\nIn terms of its value breakdown, the stock currently trades at 16.7X current fiscal year EPS estimates, which is not in-line with the peer industry average of 18.9X. On a trailing cash flow basis, the stock currently trades at 11.5X versus its peer group's average of 11.7X. Additionally, the stock has a PEG ratio of 1.66. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.\nZacks Rank\nWe also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Cencora currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.\nSince we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cencora fits the bill. Thus, it seems as though Cencora shares could have potential in the weeks and months to come.\nHow Does COR Stack Up to the Competition?\nShares of COR have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is HealthEquity, Inc. (HQY). HQY has a Zacks Rank of # 2 (Buy) and a Value Score of C, a Growth Score of A, and a Momentum Score of F.\nEarnings were strong last quarter. HealthEquity, Inc. beat our consensus estimate by 22.86%, and for the current fiscal year, HQY is expected to post earnings of $3.09 per share on revenue of $1.18 billion.\nShares of HealthEquity, Inc. have gained 19.5% over the past month, and currently trade at a forward P/E of 32.47X and a P/CF of 29.31X.\nThe Medical Services industry may rank in the bottom 56% of all the industries we have in our universe, but there still looks like there are some nice tailwinds for COR and HQY, even beyond their own solid fundamental situation.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nCencora, Inc. (COR) : Free Stock Analysis Report\nHealthEquity, Inc. (HQY) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483836508"}